1 study on Scyreprocin curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research highlights scyreprocin's significant potential as a new therapeutic agent against challenging MDR bacterial infections, offering a much-needed alternative to failing conventional antibiotics. Its low pro…